---
DrugClass: "[[Immune Modulating Therapies]]"
SubClass: "[[Checkpoint inhibitors]]"
DrugClassAdverse: "[[Checkpoint inhibitors#Adverse Reactions]]"
DrugClassContra: "[[Checkpoint inhibitors#Contraindications]]"
BrandName: Zejula
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "51"
KindleLinkChap: "[Chapter 51](kindle://book?action=open&asin=B09FRF11YJ&location=30282)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: PARP Enzyme Inhibitors
---
```smiles
C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Solid tumors: female genitourinary (GU) 


### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Fatigue, headache, decreased appetite, taste changes, nausea, vomiting, diarrhea, muscle pain

### Interactions

`= this.ChemLink+this.file.name`

